Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 25;5(1):28–36. doi: 10.1093/nop/npx008

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)

PMC Copyright notice

Fig. 2 — A 12-year-old boy with cerebellar pilocytic astrocytoma (patient 2). Images prior to starting bevacizumab: (a)¹⁸F-FDOPA PET (b) T1-weighted MRI with contrast (c) Fluid-attenuated inversion recovery (FLAIR) MRI (d)¹⁸F-FDOPA PET/MRI. Images obtained 4 weeks following bevacizumab: (e)¹⁸F-FDOPA PET (f) T1-weighted MRI with contrast (g) FLAIR MRI (h)¹⁸F-FDOPA PET/MRI, showing near complete resolution of the tumor.